SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (880)12/19/2017 8:46:07 PM
From: tuck   of 897
 
Galectin (GALT) fakes right (with shelf), goes left (gets line of credit from new - elected last week - Director). Nifty. There are warrants, and half of them vest immediately, but the strike price is $5. This buys them a bit over a year without immediate dilution, so the stock is fireworking after hours, spiking to $2.50. Reminds me of MannKind. Although that company at least got their product to market. I doubt GALT will.

But that erases a decent profit on my position if it holds. To add on the spike? Might well.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News